Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2010

View Archived Issues

Novartis gains exclusive rights to Debiopharm's alisporivir for hepatitis C

ALK-Abello reports final follow-up results from GT-08 trial of Grazax

VaxGen stockholder vote insufficient to approve merger with OXiGENE

Westaim merges with Nucryst to form Westaim Holdings

SciClone and Sigma-Tau report topline results of Zadaxin trial in H1N1

Ono Pharmaceutical reports results from third quarter of 2009, ended December 31

Phase I data support safety and tolerability of ADMVA HIV candidate vaccine

Denosumab superior to Zometa in prostate cancer patients with bone metastases

Hsp32 implicated in protective effects of celastrol in hair cell death

Palatin Technologies doses first male cohort in bremelanotide safety trial

Baclofen shown to inhibit salicylate and noise-induced tinnitus in rats

Minocycline ameliorates neomycin-induced hearing loss in gerbils

Novel PET imaging agents identified by Merck & Co.

Takeda studies concomitant use of dexlansoprazole and other PPIs with Plavix

Sirtris Pharmaceuticals discovers SIRT activators

Novel ACC inhibitors in early development at Pfizer

Progenics reports the identification of a wide range of PI3K inhibitors

GSK claims novel triple monoamine reuptake inhibitors for affective disorders

Kamada enrolls first patient in pivotal study of inhaled AAT

Xoma initiates phase IIb dose-finding XOMA-052 trial in type 2 diabetes

Psyadon initiates clinical trial of ecopipam in Lesch-Nyhan disease

Chelsea Therapeutics advances neurogenic orthostatic hypotension program

Tibotec's Prezista approved in Canada as part of combination therapy for pediatric HIV

AnaptysBio and Merck & Co. enter into antibody development collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...